BURWIG SUSAN E sold $13.5M of MEDP
BURWIG SUSAN E (Exec. VP, Operations) sold 20,000 shares of Medpace Holdings, Inc. (MEDP) at $677.00 ($13.54M total) across 2 trades over 2026-10-26 to 2026-10-27.
How this was made
The 30-second read
Why it matters
The disclosed sale adds new material information that could affect MEDP's short‑term price dynamics.
Market read
Insider sales of this magnitude are noteworthy for traders monitoring biotech stocks.
What to watch
No 10b5‑1 plan was in place, suggesting the timing was discretionary.
Background
Form 4 filings provide the first public disclosure of insider transactions.
Ticker impact
Executive VP of Operations sold 20,000 shares for $13.54 M via open‑market trades, disclosed in a Form 4 filing.
likely downward pressure as the market prices in the insider sell
A $13.5 M sale by a senior officer is material for a mid‑cap biotech and often triggers short‑term selling.
Market effects
May raise concerns for other biotech firms with recent insider sales.
Limited to U.S. biotech investors.
Low; impact confined to MEDP and its peers.
Counterpoint
The sale could be a routine portfolio rebalancing unrelated to company fundamentals.
Key entities
- OfficerBURWIG SUSAN E
Executive Vice President, Operations at Medpace Holdings.



